Cargando…

Corrigendum: Systems pharmacology approach to investigate the mechanism of Kai-Xin-San in Alzheimer’s disease

Detalles Bibliográficos
Autores principales:	Luo, Yunxia, Li, Dongli, Liao, Yanfang, Cai, Chuipu, Wu, Qihui, Ke, Hanzhong, Liu, Xinning, Li, Huilin, Hong, Honghai, Xu, Yumin, Wang, Qi, Fang, Jiansong, Fang, Shuhuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588629/ https://www.ncbi.nlm.nih.gov/pubmed/37869758 http://dx.doi.org/10.3389/fphar.2023.1239060

Ejemplares similares

Systems Pharmacology Approach to Investigate the Mechanism of Kai-Xin-San in Alzheimer’s Disease
por: Luo, Yunxia, et al.
Publicado: (2020)

Systems pharmacology-based approach to investigate the mechanisms of Danggui-Shaoyao-san prescription for treatment of Alzheimer’s disease
por: Wu, Qihui, et al.
Publicado: (2020)

Kai Xin San ameliorates scopolamine-induced cognitive dysfunction
por: Xu, Yu-Min, et al.
Publicado: (2019)

Antidepressant effects of Kai-Xin-San in fluoxetine-resistant depression rats
por: Dong, X.Z., et al.
Publicado: (2017)

Integrated meta-analysis, network pharmacology, and molecular docking to investigate the efficacy and potential pharmacological mechanism of Kai-Xin-San on Alzheimer's disease
por: Yi, Pengji, et al.
Publicado: (2020)

Study on the Multitarget Synergistic Effects of Kai-Xin-San against Alzheimer's Disease Based on Systems Biology
por: Guo, Sirui, et al.
Publicado: (2019)

Kai-Xin-San Inhibits Tau Pathology and Neuronal Apoptosis in Aged SAMP8 Mice
por: Jiao, Ya-Nan, et al.
Publicado: (2022)

Kai-Xin-San protects against mitochondrial dysfunction in Alzheimer’s disease through SIRT3/NLRP3 pathway
por: Su, ShiJie, et al.
Publicado: (2023)

Behavioral and biochemical effects of a formulation of the traditional Chinese medicine, Kai-Xin-San, in fatigued rats
por: HU, YUAN, et al.
Publicado: (2013)

Classic Prescription, Kai-Xin-San, Ameliorates Alzheimer's Disease as an Effective Multitarget Treatment: From Neurotransmitter to Protein Signaling Pathway
por: Guo, Sirui, et al.
Publicado: (2019)

Comprehensive assessment of side effects in COVID-19 drug pipeline from a network perspective
por: Wu, Qihui, et al.
Publicado: (2020)

Kai-Xin-San, a Chinese Herbal Decoction, Accelerates the Degradation of β-Amyloid by Enhancing the Expression of Neprilysin in Rats
por: Wang, Na, et al.
Publicado: (2020)

Aberrant Expression Profiles of lncRNAs and Their Associated Nearby Coding Genes in the Hippocampus of the SAMP8 Mouse Model with AD
por: Hong, Honghai, et al.
Publicado: (2020)

Kai-Xin-San Protects Depression Mice Against CORT-Induced Neuronal Injury by Inhibiting Microglia Activation and Oxidative Stress
por: Bai, Guiqin, et al.
Publicado: (2022)

Neuroprotective mechanism of Kai Xin San: upregulation of hippocampal insulin-degrading enzyme protein expression and acceleration of amyloid-beta degradation
por: Wang, Na, et al.
Publicado: (2017)

Network Proximity-based computational pipeline identifies drug candidates for different pathological stages of Alzheimer's disease
por: Wu, Qihui, et al.
Publicado: (2023)

Identification of protein targets for the antidepressant effects of Kai-Xin-San in Chinese medicine using isobaric tags for relative and absolute quantitation
por: Dong, Xian-Zhe, et al.
Publicado: (2019)

MiR-1281 is involved in depression disorder and the antidepressant effects of Kai-Xin-San by targeting ADCY1 and DVL1
por: Chen, Chao, et al.
Publicado: (2023)

A Comparative Study of Serum Pharmacochemistry of Kai-Xin-San in Normal and AD Rats Using UPLC-LTQ-Orbitrap-MS
por: Yang, Lin, et al.
Publicado: (2022)

Editorial: Traditional medicine and phytochemicals for neurodegenerative diseases treatment: application of interdisciplinary technologies in novel therapeutic target and drug discovery
por: Cai, Chuipu, et al.
Publicado: (2023)

Kai-Xin-San, a traditional Chinese medicine formulation, exerts antidepressive and neuroprotective effects by promoting pCREB upstream pathways
por: Dong, Xian-Zhe, et al.
Publicado: (2016)

Jia-Wei-Kai-Xin-San Treatment Alleviated Mild Cognitive Impairment through Anti-Inflammatory and Antiapoptotic Mechanisms in SAMP8 Mice
por: Zhang, Xiaolu, et al.
Publicado: (2023)

Kai-Xin-San series formulae alleviate depressive-like behaviors on chronic mild stressed mice via regulating neurotrophic factor system on hippocampus
por: Zhu, Yue, et al.
Publicado: (2017)

A Chinese herbal decoction, reformulated from Kai-Xin-San, relieves the depression-like symptoms in stressed rats and induces neurogenesis in cultured neurons
por: Yan, Lu, et al.
Publicado: (2016)

Kai-Xin-San Attenuates Doxorubicin-Induced Cognitive Impairment by Reducing Inflammation, Oxidative Stress, and Neural Degeneration in 4T1 Breast Cancer Mice
por: Lyu, Wenjiao, et al.
Publicado: (2021)

Systems pharmacology dissection of pharmacological mechanisms of Xiaochaihu decoction against human coronavirus
por: Xu, Lvjie, et al.
Publicado: (2023)

A Standardized Chinese Herbal Decoction, Kai-Xin-San, Restores Decreased Levels of Neurotransmitters and Neurotrophic Factors in the Brain of Chronic Stress-Induced Depressive Rats
por: Zhu, Kevin Yue, et al.
Publicado: (2012)

A Modified Chinese Herbal Decoction (Kai-Xin-San) Promotes NGF-Induced Neuronal Differentiation in PC12 Cells via Up-Regulating Trk A Signaling
por: Yan, Lu, et al.
Publicado: (2017)

Kai-Xin-San, a Chinese Herbal Decoction Containing Ginseng Radix et Rhizoma, Polygalae Radix, Acori Tatarinowii Rhizoma, and Poria, Stimulates the Expression and Secretion of Neurotrophic Factors in Cultured Astrocytes
por: Zhu, Kevin Yue, et al.
Publicado: (2013)

In silico identification of natural products from Traditional Chinese Medicine for cancer immunotherapy
por: Cai, Chuipu, et al.
Publicado: (2021)

An Insight Into the Molecular Mechanism of Berberine Towards Multiple Cancer Types Through Systems Pharmacology
por: Guo, Pengfei, et al.
Publicado: (2019)

Jia-Wei-Kai-Xin-San, an Herbal Medicine Formula, Ameliorates Cognitive Deficits via Modulating Metabolism of Beta Amyloid Protein and Neurotrophic Factors in Hippocampus of Aβ(1-42) Induced Cognitive Deficit Mice
por: Zhu, Yue, et al.
Publicado: (2019)

Bushen-Yizhi formula ameliorates mitochondrial dysfunction and oxidative stress via AMPK/Sirt1 signaling pathway in D-gal-induced aging rats
por: Liao, Yanfang, et al.
Publicado: (2023)

Chinese Medicine Formula Kai-Xin-San Ameliorates Neuronal Inflammation of CUMS-Induced Depression-like Mice and Reduces the Expressions of Inflammatory Factors via Inhibiting TLR4/IKK/NF-κB Pathways on BV2 Cells
por: Qu, Suchen, et al.
Publicado: (2021)

A novel role of HuR in ‐Epigallocatechin‐3‐gallate (EGCG) induces tumour cells apoptosis
por: Jian, Wenxuan, et al.
Publicado: (2019)

In silico Identification and Mechanism Exploration of Hepatotoxic Ingredients in Traditional Chinese Medicine
por: Wu, Qihui, et al.
Publicado: (2019)

Rapid HPLC Quantification Approach for Detection of Active Constituents in Modern Combinatorial Formula, San-Huang-Xie-Xin-Tang (SHXXT)
por: Wu, Tung-Ying, et al.
Publicado: (2016)

TCMIO: A Comprehensive Database of Traditional Chinese Medicine on Immuno-Oncology
por: Liu, Zhihong, et al.
Publicado: (2020)

The Use of San-Huang-Xie-Xin-Tang Reduces the Mortality Rate among Breast Cancer Patients
por: Winardi, Daniel, et al.
Publicado: (2023)

The influence of KaiA mutations on its function in the KaiABC circadian clock system
por: Chen, Qiang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_eouje9r8gfu9rs637cfdkrl0v9